Open Access Open Access  Restricted Access Subscription Access

Quercetin as Neuroprotective Agent: Mechanistic and Therapeutic Potential in Neurodegenerative Diseases

Kajal .

Abstract


Neurodegenerative diseases Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis, lead to ongoing loss of neurons, cognitive decreased, movement problem, oxidative stress, and long-term inflammation in the brain. The increasing  global impact of these diseases calls for effective prevention and treatment Quercetin is a natural flavonoid found in many fruits and vegetables, has shown potential as a neuroprotective because of its biological effects. It summarizes the pharmacological role , production, metabolism, and protective role of quercetin in relation to neurodegenerative diseases. Research from both in- vitro and in-vivo studies shows that quercetin has strong antioxidant effects. It works by decreasing reactive oxygen species, binding to metal ions, and boosting natural antioxidant enzymes,and oxidative stress. Quercetin also enhance neuroinflammation by blocking NF-by, MAPK, and STAT3 signaling, decreased microglial activation, and promote anti-inflammatory cytokines like IL-10. It impacts the buildup of harmful proteins, such as amyloid-β, tau, and α-synuclein increases breakdown via  the ubiquitin-proteasome system and autophagy. Quercetin helps neurons survive by encouraging new nerve cell growth, increasing neurotrophic factors.


Full Text:

PDF

References


Cummings JL, Tong G, Ballard C. Treatment Combinations for Alzheimer’s Disease: Current and Future Pharmacotherapy Options. J Alzheimers Dis. 2019;67(3):779–94. doi:10.3233/JAD-180766 PubMed PMID: 30689575; PubMed Central PMCID: PMC6398562.

Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, Copeland NG, et al. Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiology of disease. 2002;10(2):128–38.

Wang C, Lu R, Ouyang X, Ho MW, Chia W, Yu F, et al. Drosophila overexpressing parkin R275W mutant exhibits dopaminergic neuron degeneration and mitochondrial abnormalities. Journal of Neuroscience. 2007;27(32):8563–70.

Russell KN, Mitchell NL, Anderson NG, Bunt CR, Wellby MP, Melzer TR, et al. Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses. Brain and Behavior. 2018 Sep;8(9):e01096. doi:10.1002/brb3.1096

Jellinger KA. Basic mechanisms of neurodegeneration: a critical update. J Cellular Molecular Medi. 2010 Mar;14(3):457–87. doi:10.1111/j.1582-4934.2010.01010.x

Guimaraes JS, Freire MAM, Lima RR, Souza-Rodrigues RD, Costa AM, Dos Santos CD, et al. Mechanisms of secondary degeneration in the central nervous system during acute neural disorders and white matter damage. Rev Neurol. 2009;48(6):304–10.

Ebstein SY, Yagudayeva I, Shneider NA. Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a TARDBP knockin mouse model of ALS. Cell reports. 2019;26(2):364–73.

De Olmos JS, Beltramino CA, De Lorenzo SDO. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicology and teratology. 1994;16(6):545–61.

Burnstock G. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology. 2016 May 1;Special Issue: Purines in Neurodegeneration and Neuroregeneration104:4–17. doi:10.1016/j.neuropharm.2015.05.031

Treinin M, Chalfie M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron. 1995 Apr;14(4):871–7. doi:10.1016/0896-6273(95)90231-7


Refbacks

  • There are currently no refbacks.